Tag Archives: truvada

Breaking News: FDA Approves First Drug Proven To Reduce The Risk Of HIV Infection

FDA Approves First Drug Proven To Reduce The Risk Of HIV Infection A breakthrough in the fight against HIV was announced earlier today. The U.S. Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes AIDS. The agency approved Gilead Sciences’ pill Truvada as a preventive measure for people who are at high risk of acquiring HIV through sexual activity, such as those who have HIV-infected partners. Public health advocates say the approval could help slow the spread of HIV, which has held steady at about 50,000 new infections per year for the last 15 years. An estimated 1.2 million Americans have HIV, which develops into AIDS unless treated with antiviral drugs. With an estimated 240,000 HIV carriers unaware of their status, doctors and patients say new methods are needed to fight the spread of the virus. Gilead Sciences Inc. has marketed Truvada since 2004 as a treatment for people who are already infected with the virus. But starting in 2010, studies showed that the drug could actually prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 percent, when accompanied by condoms and counseling. Last year another study found that Truvada reduced infection by 75 percent in heterosexual couples in which one partner was infected with HIV and the other was not. Awesome news! Source

Read more here:
Breaking News: FDA Approves First Drug Proven To Reduce The Risk Of HIV Infection

For Your Information: The FDA Advisory Panel Recommends Approval For HIV-Prevention Drug Truvada

Truuuuuuuuuu! FDA May Approve HIV Pill Truvada For Mass Consumption The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS. In a series of votes, a Food and Drug Administration advisory panel recommended approval of the daily pill Truvada for healthy people who are at high risk of contracting HIV, including gay and bisexual men and heterosexual couples with one HIV-positive partner. The FDA is not required to follow the panel’s advice, though it usually does. A final decision is expected by June 15. Gilead Sciences Inc., based in Foster City, Calif., has marketed Truvada since 2004 as a treatment for people who are infected with the virus. The medication is a combination of two older HIV drugs, Emtriva and Viread. Doctors usually prescribe it as part of a drug cocktail to repress the virus. While panelists ultimately backed Truvada for prevention, Thursday’s 12-hour meeting highlighted a number of concerns created by the first drug to prevent HIV. In particular, the panel debated whether Truvada might lead to reduced use of condoms, the most reliable defense against HIV. The experts also questioned the drug’s effectiveness in women, who have shown much lower rates of protection in studies. Panelists struggled to outline steps that would ensure patients take the pill every day. In clinical trials, patients who didn’t take their medication diligently were not protected, and patients in the real world are even more likely to forget than those in studies. Says one doctor about the controversial drug: “The trouble is adherence, but I don’t think it’s our charge to judge whether people will take the medicine,” said Dr. Tom Giordano of Baylor College of Medicine, who voted in favor of the drug. “I think our charge is to judge whether it works when it’s taken and whether the risks outweigh the benefits.” Once again, this pill is not a “I don’t need no condom baby, I take Truvada” situation. Strapping up will always be the most effective way to prevent the spread of disease, however this drug would definitely be a breakthrough in the fight against HIV/AIDS Source

Visit link:
For Your Information: The FDA Advisory Panel Recommends Approval For HIV-Prevention Drug Truvada